J Am Coll Nutr 2005. 1 June 2005; 24 (3) pdfs availed

[Guest guest]

Hi All,

The below not yet in Medline papers of J Am Coll Nutr 2005; 1 June 2005; 24 (3)

pdfs

are availed. Below are the titles and three abstract excerpts.

SNACK FOODS: COMPARING NUTRITION VALUES OF EXCELLENT CHOICES AND " JUNK FOODS "

W. and Katy

J Am Coll Nutr 2005. 24: 155-156.

RESPONSE: SNACK FOODS, OBESITY AND REALISTIC RECOMMENDATIONS

M. Klurfeld

J Am Coll Nutr 2005. 24: 156-157.

REVIEWS

Strategies for Healthy Weight Loss: From Vitamin C to the Glycemic Response

Carol S. ston

J Am Coll Nutr 2005. 24: 158-165.

ORIGINAL RESEARCH

Dietary Magnesium and C-reactive Protein Levels

Dana E. King, Arch G. Mainous, III, Mark E. Geesey, and F. Woolson

J Am Coll Nutr 2005. 24: 166-171.

Decreasing Oxidative Stress with Choline and Carnitine in Women

Dileep S. Sachan, Nobuko Hongu, and Maike sen

J Am Coll Nutr 2005. 24: 172-176.

Association between Dietary Conjugated Linoleic Acid and Bone Mineral Density

in

Postmenopausal Women

Rhonda A. Brownbill, Petrosian, and Jasminka Z. Ilich

J Am Coll Nutr 2005. 24: 177-181.

Comparison of Hormone and Glucose Responses of Overweight Women to Barley and

Oats

Kay M. Behall, J. Scholfield, and Judith Hallfrisch

J Am Coll Nutr 2005. 24: 182-188.

Lipid Responses to a Dietary Docosahexaenoic Acid Supplement in Men and Women

with

Below Average Levels of High Density Lipoprotein Cholesterol

C. Maki, E. Van Elswyk, Deanna McCarthy, Serena P. Hess,

E.

Veith, Marjorie Bell, Papasani Subbaiah, and H. son

J Am Coll Nutr 2005. 24: 189-199.

.... docosahexaenoic acid (DHA) supplement in men and women with below-average

levels

of high-density lipoprotein (HDL) cholesterol.

Methods: This randomized, double-blind, controlled clinical trial included 57

subjects, 21–80 years of age, with fasting HDL cholesterol concentrations 44

mg/dL

(men) and 54 mg/dL (women), but 35 mg/dL. Subjects were randomly assigned to

receive

either 1.52 g/day DHA from capsules containing DHA-rich algal triglycerides or

olive

oil (control) for six weeks.

Results: There were no significant differences between groups in baseline lipid

values. The DHA supplemented group showed significant changes [–43 (DHA) vs. –14

(controls) mg/dL, p = 0.015] and percent changes [–21% (DHA) vs. –7% (controls),

p =

0.009] in triglycerides, total (12 vs. 3 mg/dL; p = 0.021 and 6% vs. 2%; p =

0.018)

and low-density lipoprotein (17 vs. 3 mg/dL; p = 0.001 and 12% vs. 3%; p =

0.001)

cholesterol concentrations, and in the triglyceride to HDL cholesterol ratio

(–1.33

vs. –0.50, p = 0.010), compared with controls. In addition, there was a

significant

reduction in the percentage of LDL cholesterol carried by small, dense particles

in

the DHA supplemented group (changes = –10% vs. –3%, p = 0.025).

Conclusions: Supplementation with 1.52 g/d of DHA in men and women with

below-average HDL cholesterol concentrations raised the LDL cholesterol level,

but

had favorable effects on triglycerides, the triglyceride/HDL cholesterol ratio

and

the fraction of LDL cholesterol carried by small, dense particles. ...

Inhibition of Osteoporosis in Autoimmune Disease Prone MRL/Mpj-Faslpr Mice by

N-3

Fatty Acids

Arunabh Bhattacharya, Mizanur Rahman, Jameela Banu, A. Lawrence,

S. McGuff, I.R. Garrett, Fischbach, and Fernandes

J Am Coll Nutr 2005. 24: 200-209.

Rheumatoid arthritis (RA) is a systemic autoimmune inflammatory disease

involving

the breakdown of cartilage and juxta-articular bone, which is often accompanied

by

decreased bone mineral density (BMD) and increased risk of fracture.

Anti-inflammatory omega-3 fatty acids may prevent arthritis and bone loss in

MRL/lpr

mice model of arthritis and in humans.

Methods: In this study, the effect of long term feeding of 10% dietary n-3 (fish

oil

(FO)) and n-6 (corn oil (CO)) fatty acids begun at 6 weeks of age on bone

mineral

density (BMD) in different bone regions in an MRL/lpr female mouse model of RA

was

measured at 6, 9, and 12 months of age by dual energy x-ray absorptiometry

(DEXA).

After sacrificing the mice at 12 months of age, antioxidant enzyme activities

were

measured in spleen, mRNA for receptor activator of NF-B ligand (RANKL) and

osteoprotegerin (OPG) was measured by RT-PCR in lymph nodes, and synovitis was

measured in leg joints.

Results: At 6, 9 and 12 months of age, BMD was significantly higher (p < 0.05)

in

distal femur, proximal tibia, and lumbar spine of FO fed mice than those of CO

fed

mice. Spleen catalase (CAT) and superoxide dismutase (SOD) activities were also

significantly higher (p < 0.01) in FO fed mice than in CO fed mice. Histology of

knee joints revealed mild synovitis in CO fed mice, which was not present in FO

fed

mice. RT-PCR analysis of lymph nodes revealed decreased RANKL mRNA (p < 0.001)

expression and enhanced OPG mRNA expression (p < 0.01) in FO fed mice compared

to CO

fed mice.

Conclusions: These results suggest beneficial effects of long-term FO feeding in

maintaining higher BMD and lower synovitis in this mouse model. These beneficial

effects may be due, in part, to increased activity of antioxidant enzymes,

decreased

expression of RANKL, and increased expression of OPG in FO fed mice thereby

altering

the RANKL/OPG ratio. ...

Weight Loss and Lipid Changes with Low-Energy Diets: Comparator Study of

Milk-Based

versus Soy-Based Liquid Meal Replacement Interventions

W. and Lars H. Hoie

J Am Coll Nutr 2005. 24: 210-216.

.... meal replacements (MR) we assessed weight loss and serum lipoproteins

changes

for obese subjects who consumed low-energy diets (LED) including either

milk-based

or soy-based MR.

Methods: Overweight or obese women and men (body mass indices 27–40 kg/m2) were

randomly assigned to LED providing 1200 kcal/day, with consumption of five

soy-based

or two milk-based liquid MR for a 12-week weight loss trial. Serum lipoprotein

measurements were obtained at baseline, 6 and 12 weeks.

Results: For soy and milk MR groups, subject numbers were, respectively, 51 and

39

randomized and 30 and 22 completers. MR use averaged: soy, 3.7/day; and milk,

1.9/day. Weight losses for completers at 12 weeks were: soy MR, 9.0% of initial

body

weight (95% confidence intervals, 7.3–10.6%); and milk MR, 7.9% (5.8–8.8%) with

no

significant differences. Reductions from baseline in serum cholesterol and

LDL-cholesterol values, respectively, at six weeks were significantly greater (P

<

0.015) with soy MR (15.2% and 17.4%) than with milk MR (7.9% and 7.7%). Soy MR

use

was associated with significant reductions in serum triglycerides at 6 and 12

weeks

while milk MR use was not.

Conclusions: Soy MR use, as part of a low-energy diet, was associated with

slightly

but not significantly greater weight loss over a 12-week period than milk MR

use.

....

Plasma Carotenoid and Vitamins A and E Concentrations in Older African American

Women after Wheat Bran Supplementation: Effects of Age, Body Mass and Smoking

History

Boyd R. Switzer, Jan R. Atwood, Aliza H. Stark, W. Hatch,

,

Fred Ullrich, R. Lyden, Xiumei Wu, Yulanda Chiu, and Jan L.

J Am Coll Nutr 2005. 24: 217-226.

Al Pater, PhD; email: old542000@...

__________________________________

Discover

Use to plan a weekend, have fun online and more. Check it out!

http://discover./